FACULTY &
TOPICS
Overview of the 2017 ASPEN ILE Survey With Gap
Analysis
Phil Ayers,
PharmD, BCNSP, FASHP
Overview and History of ILEs Available in the United
States
Jay Mirtallo,
MS, RPh, BCNSP, FASHP, FASPEN
Fatty Acid Metabolism and Essential Fatty Acid (EFA) Needs
John Miles,
MD
The Use of Alternative ILEs in the Peadiatirc
Population
Kathleen Gura,
PharmD, BCNSP
The Utility of Alternative ILEs in the Adult
Population
Todd Mattox,
PharmD, BCNSP
MODERATOR
Phil Ayers,
PharmD, BCNSP, FASHP
LEARNING
OBJECTIVES
- Summarize the
2017 ASPEN Lipid Survey and Gap Analysis including key findings
- Compare and
contrast currently available, FDA approved ILEs in the US
- Dose ILEs
appropriately to achieve adequate EFAs and calories
- Solve patient
specific cases regarding lipid dosing in both adult and pediatric populations
LEARNING LEVEL: Intermediate
UAN: JA0002345-0000-19-050-L04-P
CE CREDIT: 1.5
hours